Solstice Biologics LLC — Form D
Solstice Biologics LLC of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-03. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-10-03
- Form: D
- Accession: 0001140361-14-037296
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Investors: 2
- Date of first sale: 2014-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-225788
Issuer
- Name: Solstice Biologics LLC
- CIK: 0001564178
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1700 OWENS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-800-0800
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| FRANK MUHLENBECK | Director | SAN DIEGO, CA |
| Louis Tartaglia | Director | BOSTON, MA |
| Corey Goodman | Director | Cambridge, MA |
| Corey Goodman | Executive Officer | Cambridge, MA |
| Corey Goodman | Promoter | Cambridge, MA |
| Robert Adelman | Director | San Francisco, CA |
| John Borgeson | Executive Officer | Palo Alto, CA |
| Curt Bradshaw | Director | San Francisco, CA |
| Curt Bradshaw | Executive Officer | San Francisco, CA |
| Curt Bradshaw | Promoter | San Francisco, CA |
| Steven Dowdy | Director | San Fransciso, CA |
| George Rehm | Director | Tiburon, CA |
Other filings by this issuer (3)
More